Shifting focus in optical image-guided cancer therapy

Stijn Keereweer1, Pieter B A A Van Driel, Dominic J Robinson

  • 1Department of Molecular Imaging, Leiden University Medical Center, Leiden, The Netherlands, s.keereweer@erasmusmc.nl.

Summary

New fluorescence imaging techniques targeting the follicle-stimulating hormone receptor (FSHR) could improve cancer surgery by better defining tumor margins and addressing tumor heterogeneity, potentially guiding adjuvant therapies.

Related Concept Videos